Insights

In-depth articles and expert analysis from pharmaceutical leaders, exploring advances in life sciences, drug development and the trends shaping healthcare innovation.

Pharmatica image of a glass globe illuminated from within by bright yellow light, surrounded by blue data lines, symbolising AI bringing light, intelligence, and innovation to global healthcare through the Anthropic and Gates Foundation Partnership.

Artificial Intelligence in Healthcare AI Pharma AI & Machine Learning

Anthropic’s Gates Foundation Partnership and Healthcare AI

Nicole Dale

Pharmatica image representing AI and machine learning in sterile pharmaceutical manufacturing. The image shows precision glass ampoules with a digital data mesh overlay, symbolising AI-driven quality and contamination detection.

Sterile Manufacturing Quality Continuous Manufacturing

Can AI and Machine Learning in Sterile Manufacturing Improve Quality?

Nicole Dale

Optimising clinical trial data collection Pharmatica image representing fit-for-purpose evidence generation.

Clinical Data Clinical Outcomes Clinical Trial Design

Optimising Clinical Trial Data Collection for Better Decisions

Nicole Dale

Pharmatica image showing a pharmaceutical R&D portfolio management meeting reviewing drug discovery pipeline progression, translational science, and pharmaceutical R&D success rates using evidence-based portfolio strategy.

What Drives Pharmaceutical R&D Success? New Benchmarking Reveals Why Some Drug Pipelines Outperform Others

Pharmatica image showing a clinical geneticist using LLM-assisted rare disease diagnosis tools to analyse genome sequencing data and generate evidence-based diagnostic hypotheses for precision medicine.

Can Large Language Models Solve More Rare Disease Genomes?

Pharmatica image showing modular pharmaceutical manufacturing using continuous pharmaceutical manufacturing processes, interconnected production modules, and Process Analytical Technology to improve flexible drug manufacturing.

Modular Pharma Factories: The Next Step for Continuous Manufacturing?

Explore All Insights

Browse our complete library of expert articles and analysis. Explore content across science, policy and life sciences innovation.

Nicole Dale

One Pivotal Trial for FDA Approval? Success Depends on Trial Design

Pharmatica image of a modern pharmaceutical regulatory affairs workspace representing documentation, compliance, and submission processes essential for FDA drug approval. The scene shows three binders labeled “Regulatory Affairs,” “Submissions,” and “Compliance” on a clean office desk with documents and a pen in the foreground, while a blurred meeting of professionals is visible through a glass wall in the background. The composition conveys administrative precision and regulatory science underpinning.

One pivotal trial for FDA approval could accelerate drug development, reshape clinical trial strategy, and change the pharmaceutical regulatory landscape.

Nicole Dale

Great Drug Discovery Starts with Great Scientists

Pharmatica image of a modern pharmaceutical research laboratory representing drug discovery scientists using computational biology, structural biology, medicinal chemistry, and AI-assisted therapeutic research.

Learn how drug discovery scientists are evolving alongside AI, computational biology, and multidisciplinary research to accelerate therapeutic innovation.

Nicole Dale

Claude Science: An Operating System for AI-Driven Pharma R&D

Pharmatica photo‑realistic representation of scientists collaborating in a unified AI‑driven pharmaceutical research environment using Claude Science, integrating genomics, structural biology, cheminformatics, and AI-assisted pharmaceutical research

Claude Science is a new AI R&D tool for drug discovery, integrating 60-plus scientific databases into one place. Here is what pharma R&D teams need to know.

Nicole Dale

Europe’s Life Sciences Strategy. A New Era of Innovation?

Pharmatica picture of European pharmaceutical innovation showing biotechnology research, advanced manufacturing, artificial intelligence, and regulatory collaboration supporting the European Life Sciences Strategy.

The new European Life Sciences Strategy aims to accelerate pharmaceutical innovation through investment, regulatory reform, biotechnology, and AI capabilities.

Nicole Dale

One Global CMC Dossier? Digital Regulatory Submissions

Pharmatica photo‑realistic representation of CMC regulatory submissions showing global data networks, secure digital dossier exchange, and pharmaceutical manufacturing integration — document binders, connected globe, red padlock cybersecurity icon, and industrial equipment with red‑capped vials illustrate digital CMC submissions, regulatory reliance, and manufacturing quality.

Discover how digital CMC regulatory submissions, cloud collaboration, and AI accelerate the modernisation of manufacturing approvals and global pharma operations.

Nicole Dale

Deep Learning in Clinical Trials for 2026 and Beyond

Pharmatica representation of deep learning in clinical trials, especially AI‑driven patient recruitment in clinical trials with a realistic laboratory setting and data visualisations, global site maps, and trial analytics dashboards illustrating machine learning in clinical trials, patient recruitment AI, and adaptive trial design AI.

Deep learning is changing how clinical trials are designed, run, and analysed in 2026. Examine the tools, outcomes, and strategic risks shaping adoption.

Nicole Dale

GLP-1 Drug Discovery Success Transformed Pharmaceutical R&D

Pharmatica photorealistic illustration of GLP-1 drug discovery showing peptide molecules, metabolic signalling pathways, and obesity treatment research in a modern pharmaceutical laboratory.

From gut hormones to global therapeutics, GLP-1 drug discovery transformed obesity treatment through peptide engineering and incretin biology translation.

Nicole Dale

FDA PreCheck Pilot Program to Build Manufacturing Readiness

Pharmatica image of regulatory inspectors reviewing digital drug manufacturing systems in a pharmaceutical production facility, illustrating the FDA PreCheck Pilot Program, manufacturing readiness, U.S. domestic drug manufacturing, and advanced pharmaceutical manufacturing.

The FDA PreCheck Pilot Program aims to strengthen U.S. domestic drug manufacturing through regulatory engagement, manufacturing readiness, and advanced production.

Nicole Dale

AI and Neuroscience. Why Big Pharma Is Betting on the Brain

Pharmatica’s AI in neuroscience graphical concept showing a digital brain connected to pharmaceutical research, precision psychiatry, biomarkers, and advanced artificial intelligence technologies.

AI in neuroscience is driving big pharma investment. Discover how AI neuroscience platforms are driving precision psychiatry and psychedelic therapeutics.

Nicole Dale

FDA Master Protocol Guidance for Smarter Clinical Trials

Clinical research laboratory featuring a Master Protocol document, laboratory samples, and digital analytics, representing clinical trial efficiency for precision medicine research under the FDA Master Protocol guidance.

Explore the FDA's Master Protocol guidance and how basket, umbrella, and platform trials can improve clinical trial efficiency, especially in oncology and biologics.

Nicole Dale

Can Deep Learning Survive the Precision Medicine Paradox?

High‑resolution laboratory data visualisation screen showing molecular structures, DNA helix, and genomic charts in green and sunshine yellow against a clean white background, symbolising precision medicine and advanced drug discovery.

As precision medicine narrows patient cohorts to rare‑disease scales, deep learning models face a paradox of data scarcity and overfitting that threatens the future of clinical AI.

Nicole Dale

Operation TrialBlazer: Can the U.S. Reclaim Clinical Trial Leadership?

Operation TrialBlazer aims to reshape U.S. clinical trials by combining FDA regulatory innovation, digital technologies, and modern trial strategies to reclaim global leadership in pharmaceutical development.

Operation TrialBlazer aims to reignite U.S. clinical development by accelerating trials, modernising FDA oversight, and strengthening pharmaceutical innovation.

Topic